Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial (Q43104656)
scientific article published in April 2010
Language:
(P31) (Q13442814)
(P304) 348-355
(P433) 4
(P478) 12
(P577) Thursday, April 1, 2010
(P921) (Q3025883)
(Q6934595)
(Q269829)
(P1433) (Q5270109)
(P1476) "Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial" (language: en)
(P2093) H M R Pattzi
S Pitale
M Alpizar
C Bennett
A M O'Farrell
J Li
J M Cherrington
H-P Guler
PHX1149-PROT202 Study Group
other details
description scientific article published in April 2010

External Links